Eric Siegel

30PUBLICATIONS

100CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NeonatologyPsycholinguistics (incl. speech production and comprehension)Medical mycology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (30)

Sort by Publication Date:

|May 14, 2026

A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.

|Oct 16, 2025

Equal survival for Black Americans with multiple myeloma when appropriately matched to White Americans.

David E Mery, Guido Tricot, Samer Al Hadidi

|Jul 09, 2025

Maternal and cord-blood inflammatory markers and BDNF in diabetic vs non-diabetic pregnancies.

Michael P Wendel, Heather L Moody, Eric R Siegel

|Apr 17, 2025

Chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma: a real-world experience.

Bhavesh Mohan Lal, Toshali Pandey, Marah Alzubi

|Apr 04, 2025

Does Patient Health Literacy Affect Patient Reported Outcome Measure Completion Method in Orthopaedic Patients?

Timothy J Trotter, David B Bumpass, Simon C Mears

|Feb 12, 2025

Prior exposure to belantamab mafodotin influences outcomes with idecabtagene vicleucel in patients with multiple myeloma.

Bhavesh Mohan Lal, Marah Alzubi, Jawad Alrawabdeh

Pageof 5

Frequent Collaborators

Caroline Schinke

Samer Al Hadidi

Fenghuang Zhan

Frits van Rhee

Alessandro D Santin

Timothy Cody Ashby

Mitchell Clark

Natalia Buza

Blair McNamara

Pei Hui

Frequent Collaborators

Caroline Schinke

Samer Al Hadidi

Fenghuang Zhan

Frits van Rhee